Presenting Risk Information in Prescription Drug and Medical Device Promotion
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 27, 2009
February 9, 2019
85abd709-63d2-4514-8e97-a628a63a8b2e
Related Documents
Malaria: Developing Drugs for Treatment: Draft Guidance for Industry
Guidance DocumentSeptember 23, 2025Center for Drug Evaluation and Research
Certification Process of Designated Medical Gases
Guidance DocumentNovember 25, 2015Center for Drug Evaluation and Research
Pharmacogenomic Data Submissions — Companion Guidance
Guidance DocumentAugust 28, 2007Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox